0001237899-14-000085.txt : 20141218
0001237899-14-000085.hdr.sgml : 20141218
20141218162327
ACCESSION NUMBER: 0001237899-14-000085
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141216
FILED AS OF DATE: 20141218
DATE AS OF CHANGE: 20141218
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9143477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: YANCOPOULOS GEORGE
CENTRAL INDEX KEY: 0001226690
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 141296092
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2014-12-16
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001226690
YANCOPOULOS GEORGE
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
1
0
0
President Regeneron Laboratori
Common Stock
2014-08-28
5
G
0
294.0
0.0
D
500000
D
Common Stock
2014-12-16
4
M
0
3264.0
30.63
A
503264
D
Common Stock
2014-12-16
5
G
0
3264.0
0.0
D
500000
D
Common Stock
2014-08-28
5
G
0
294.0
0.0
A
568637
I
by Trust
Common Stock
2014-11-14
5
G
0
2313.0
0.0
D
566324
I
by Trust
Common Stock
2014-12-16
5
G
0
3264.0
0.0
A
569588
I
by Trust
Common Stock
5623
I
By 401(k) Plan
Incentive Stock Option (right to buy)
30.63
2014-12-16
4
M
0
3264.0
0.0
D
2020-12-14
Common Stock
3264
0
D
Non-Qualified Stock Option (right to buy)
52.03
2014-12-16
4
A
0
240000.0
0.0
A
2021-12-16
Common Stock
240000
398079
D
Non-Qualified Stock Option (right to buy)
399.66
2014-12-16
4
A
0
172723.0
0.0
A
2024-12-16
Common Stock
172723
172723
D
The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
On December 16, 2011, the reporting person was granted an option to purchase 240,000 shares of Common Stock. The option vests, partially or in full, on December 31, 2014, based on the extent to which the company satisfies certain performance criteria during the period ending December 31, 2014. The performance criteria have been met and the option will vest as to all 240,000 shares on December 31, 2014.
The stock option award vests in four equal annual installments, commencing one year after the date of grant.
/s/**George D. Yancopoulos
2014-12-18